ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,870Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 1942

$476K Total Retail Price of All Prescriptions

Rank: 124 out of 1942

500 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 500 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

4% of this provider’s 500 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 8,104 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 605 475 1 2
SIMVASTATIN 581 467 2 1
HYDROCHLOROTHIAZIDE 425 357 3 8
OMEPRAZOLE 385 241 4 4
LEVOTHYROXINE SODIUM 382 297 5 3
METFORMIN HCL 335 262 6 10
ATENOLOL 311 279 7 7
FUROSEMIDE 300 266 8 5
METOPROLOL SUCCINATE 262 247 9 13
METOPROLOL TARTRATE 259 185 10 9
TRAMADOL HCL 239 195 11 19
FLUOXETINE HCL 210 173 12 45
WARFARIN SODIUM 160 149 13 11
AMLODIPINE BESYLATE 157 137 14 6
GABAPENTIN 156 70 15 16
ATORVASTATIN CALCIUM 135 119 16 14
SERTRALINE HCL 123 76 17 20
PROAIR HFA 117 55 18 41
ZOLPIDEM TARTRATE 113 78 19 25
ALLOPURINOL 112 105 20 26
JANTOVEN 105 105 21 33
TRAZODONE HCL 102 89 22 24
LOSARTAN POTASSIUM 94 91 23 18
AMITRIPTYLINE HCL 91 62 R 24 65
PAROXETINE HCL 91 72 24 50
IBUPROFEN 83 49 26 78
CARVEDILOL 83 62 26 39
ADVAIR DISKUS 80 53 28 35
DOXAZOSIN MESYLATE 76 66 29 72
ALENDRONATE SODIUM 74 69 30 21
LACTULOSE 74 19 30 120
RANITIDINE HCL 71 51 32 31
TRIAMTERENE-HCTZ 71 63 32 36
NOVOLOG FLEXPEN 67 35 34 107
ISOSORBIDE MONONITRATE ER 65 65 35 42
NEXIUM 62 39 36 58
LANTUS SOLOSTAR 60 32 37 54
DONEPEZIL HCL 58 58 38 30
POTASSIUM CHLORIDE 57 31 39 17
DIOVAN 56 54 40 44
GLIPIZIDE XL 55 35 41 109
FENOFIBRATE 55 20 41 82
FLUTICASONE PROPIONATE 52 23 43 37
PHENYTOIN SODIUM EXTENDED 51 15 44 138
PREDNISONE 51 45 44 27
OXYBUTYNIN CHLORIDE ER 51 42 44 118
PROPRANOLOL HCL 50 31 47 101
LEVEMIR FLEXPEN 50 35 47 179
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.